Clinical Trials Sponsored by A. Vogel

Total 6832 results

A. Vogel AG

Completed

Safety and Efficacy of the Sore Throat Lozenges to Treat Acute Sore Throats

Respiratory Tract Infection Viral | Tonsillopharyngitis

Bulgaria
A. Vogel AG

Completed

Study to Assess Safety and Efficacy of Nephrosolid Tbs to Stimulate Urinary Output in Non-patient Volunteers

Urine Specimen Collection

Switzerland
A. Vogel AG

Completed

Clinical Trial for Assessment of Safety and Efficacy of a Echinacea/Sage Spray Compared to a Chlorhexidine/Lidocaine Spray in the Treatment of Acute Sore Throats

Pharyngitis

Switzerland
A. Vogel AG

Completed

Study of Echinaforce Junior Tablets in Children With Acute Colds

Respiratory Tract Diseases

Switzerland
A. Vogel AG

Terminated

Efficacy and Safety of Sage Tablets Compared to Placebo in Menopausal Patients With Hot Flushes and Sweating

Menopausal Hot Flushes

Switzerland
A. Vogel AG

Completed

Echinacea Safety Study

Infections

United Kingdom
A. Vogel AG

Completed

Echinacea Junior vs Vitamin C in Children 4-12 Years Old

Respiratory Tract Infection Viral

Switzerland
University of Aberdeen
A. Vogel

Terminated

RIGHTWHEY - Responders In Gut HealTh Markers Using Fermented WHEY (RIGHTWHEY)

Healthy | Health, Subjective | Microbial Colonization

United Kingdom
University of Aberdeen
A. Vogel

Completed

Pilot Trial Investigating Fermented Whey Supplementation in Healthy Adults

Healthy

United Kingdom
A. Vogel AG
University of London

Unknown

Clinical Study to Assess the Influence of a Saw Palmetto Preparation in Patients With Benign Prostatic Hyperplasia (BPH) and Sexual Dysfunctions

Sexual Dysfunctions in Men With Benign Prostatic Hyperplasia

Switzerland
A. Vogel AG
University Children's Hospital, Zurich

Withdrawn

Echinaforce Junior Bioavailability Trial

Common Cold

Switzerland
A. Vogel AG
University of Newcastle Upon-Tyne

Enrolling by invitation

Mental Balance Study

Mental Health Wellness 1 | Work Related Stress

United Kingdom
A. Vogel AG
Cantonal Hospital of St. Gallen; Labormedizinisches Zentrum Dr. Risch

Completed

Superiority of Newly Developed Over Basic Echinacea Formulations for the Treatment of Respiratory Tract Infections

Respiratory Tract Infections

Switzerland
University of Michigan Rogel Cancer Center
Genzyme, a Sanofi Company

Completed

Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen

Leukemia | Multiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome

United States
A. Vogel AG
Daacro GmbH & Co. KG, Max-Planck-Str. 22, 54296 Trier/Germany

Not yet recruiting

Sleep Well Observation Study

Sleep Disturbance

Germany
A. Vogel AG
Medical University of Graz; MediStat Ltd.; Biodome Clinical; Clinical Research...

Recruiting

Echinaforce COVID-19 Shedding Study

SARS-CoV2 Infection | COVID-19 Respiratory Infection

Bulgaria
A. Vogel AG
CONVEX CRO; d.s.h. statistical services GmbH; MediStat Ltd.; Biodome Clinical; Bo... and other collaborators

Completed

Echinaforce Study to Investigate Explorative Pharmacology and Effectiveness to Prevent From Enveloped Virus Infections

Respiratory Tract Infections | Common Cold

Bulgaria
University of Michigan Rogel Cancer Center
Genzyme, a Sanofi Company; Otsuka Pharmaceutical Development & Commercialization...

Completed

Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen (CloBu4)

Acute Myeloblastic Leukemia

United States, Canada
University Hospital, Clermont-Ferrand
CEIP-A Lyon; CEIP-A Marseille; CEIP-A Caen; CEIP-A Lille; CEIP-A Montpellier; CEIP-A... and other collaborators

Completed

Prescription Opioid Misuse Assessment (POMA4)

Chronic Pain

France
University of Michigan Rogel Cancer Center

Not yet recruiting

Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Cisplatin-eligible Upper Tract Urothelial Cancer (NEPTUNE)

Urothelial Carcinoma

United States
University of Michigan Rogel Cancer Center

Recruiting

Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, Node Positive, HR+/HER2- Breast Cancer

Breast Cancer

United States
University of Michigan Rogel Cancer Center

Recruiting

Multicenter Trial of ESK981 in Patients With Select Solid Tumors

Pancreatic Adenocarcinoma | Pancreatic Neuroendocrine Tumor | Pancreatic Neuroendocrine Carcinoma | Adenosquamous Carcinoma | Gastrointestinal Neuroendocrine Tumor | Gastrointestinal Neuroendocrine Carcinoma | Neuroendocrine Prostate Carcinoma

United States
University of Michigan Rogel Cancer Center

Recruiting

Cardiac Rehabilitation to Improve Breast Cancer Outcomes (CRIBCO)

Cardiovascular Diseases | Breast Cancer

United States
University of Michigan Rogel Cancer Center

Recruiting

Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma

Glioblastoma

United States
University of Michigan Rogel Cancer Center

Recruiting

A Study of Radiation Toxicity in the Liver Using MRI-Based Perfusion

Liver Cancer

United States
University of Michigan Rogel Cancer Center

Completed

Altering Lipids for Tolerance of Aromatase Inhibitor Therapy (ALTA)

Breast Cancer

United States
University of Michigan Rogel Cancer Center

Active, not recruiting

Pembrolizumab in Combination With Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Patients With Targetable Genetic Alterations, Previously Treated With Appropriate Targeted Agents, With Progressive Disease

Non-small Cell Lung Cancer

United States
University of Michigan Rogel Cancer Center

Active, not recruiting

Gemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer (BilT-04)

Biliary Tract Cancer

United States
University of Michigan Rogel Cancer Center

Terminated

ARRx in Combination With Enzalutamide in Metastatic Castration Resistant Prostate Cancer

Prostate Cancer

United States
University of Michigan Rogel Cancer Center

Completed

Avoiding Low-value Treatments in Older Women With Early-stage Breast Cancer: Piloting a Patient Decision Aid

Breast Cancer

United States
University of Michigan Rogel Cancer Center

Active, not recruiting

A Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia (CLL) and Untreated CLL

Relapsed Chronic Lymphocytic Leukemia

United States
University of Michigan Rogel Cancer Center

Withdrawn

Trial of Devimistat in Combination With Modified FOLFIRINOX in Patients With Metastatic Adenocarcinoma of the Pancreas

Metastatic Pancreatic Adenocarcinoma

United States
University of Michigan Rogel Cancer Center

Terminated

Augmentation of the Graft vs. Leukemia Effect Via Checkpoint Blockade With Pembrolizumab

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Acute Lymphoblastic Leukemia

United States
University of Michigan Rogel Cancer Center

Completed

Study of Nivolumab in Combination With Gemcitabine/Cisplatin or Ipilimumab for Patients With Advanced Unresectable Biliary Tract Cancer

Biliary Tract Neoplasms

United States
University of Michigan Rogel Cancer Center

Active, not recruiting

Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma

Mantle Cell Lymphoma

United States
University of Michigan Rogel Cancer Center

Terminated

Testing the Effect of Mindfulness for Prostatectomy Outcomes (TEMPO)

Prostate Cancer

United States
University of Michigan Rogel Cancer Center

Completed

VISmodegib for ORbital and Periocular Basal Cell Carcinoma (VISORB)

Carcinoma, Basal Cell

United States
University of Michigan Rogel Cancer Center

Completed

Peginterferon Alfa-2a to Enhance Anti-leukemic Responses After Allogeneic Transplantation in Acute Myeloid Leukemia

Acute Myeloid Leukemia

United States
University of Michigan Rogel Cancer Center

Terminated

Ipilimumab Induction in Patients With Melanoma Brain Metastases Receiving Stereotactic Radiosurgery

Metastatic Melanoma | Brain Metastases

United States
University of Michigan Rogel Cancer Center

Completed

A Study of High-Dose Chemoradiation Using Biologically-Based Target Volume Definition in Patients With Glioblastoma

Glioma

United States
University of Michigan Rogel Cancer Center

Completed

A Pilot Study of Ruxolitinib in Secondary Hemophagocytic Syndrome

Hemophagocytic Syndrome (HPS)

United States
University of Michigan Rogel Cancer Center

Terminated

Pacritinib in Relapsed/Refractory Lymphoproliferative Disorders

Lymphoproliferative Disorders | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Lymphoma, T-Cell, Cutaneous | Chronic Lymphocytic Leukemia | Lymphoplasmacytic Lymphoma | Lymphoma, T-Cell, Peripheral

United States
University of Michigan Rogel Cancer Center

Completed

Dose Escalation Trial of AZD1775 and Gemcitabine (+Radiation) for Unresectable Adenocarcinoma of the Pancreas

Adenocarcinoma of the Pancreas

United States
University of Michigan Rogel Cancer Center

Completed

A Study of Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in Patients

Pancreatic Cancer

United States
University of Michigan Rogel Cancer Center

Completed

Pilot Study of Biomarkers and Cardiac MRI as Early Indicators of Cardiac Exposure Following Breast Radiotherapy

Breast Cancer

United States
University of Michigan Rogel Cancer Center

Completed

MRI Study of Changes in Blood-Brain/Tumor-Barrier Permeability in Patients With Brain Metastases During and After Radiotherapy

Brain Metastases

United States
University of Michigan Rogel Cancer Center

Withdrawn

Randomized Trial Comparing Stereotactic Body Radiation Therapy to Microwave Ablation for the Treatment of Localized Hepatocellular Carcinoma

Carcinoma, Hepatocellular

United States
University of Michigan Rogel Cancer Center

Completed

Veliparib With Radiation Therapy in Patients With Inflammatory or Loco-regionally Recurrent Breast Cancer

Breast Cancer

United States
University of Michigan Rogel Cancer Center

Terminated

Phase I/II Calcitriol in Lung Cancer

Non Small Cell Lung Cancer

United States
University of Michigan Rogel Cancer Center

Terminated

Trial Comparing Stereotactic Body Radiation Therapy to Radiofrequency Ablation for Renal Cell Carcinoma

Renal Cell Carcinoma

United States

Clinical Trials Sponsored by A. Vogel

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Venezuela

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations